Mariani, . G., Guidi, . L., & Barioglio, . A. (2006). Olanzapine versus typical neuroleptics for schizophrenia: evaluation of social and economic costs. Farmeconomia. Health Economics and Therapeutic Pathways, 7(2), 119–124. https://doi.org/10.7175/fe.v7i2.681